Rakesh Srivastava's (Ph.D., FRSM, FRSPH)
Owing to his prodigious knowledge and towering abilities Dr. Rakesh Srivastava (Ph.D., MBA, FRSM, FRSPH) has edited several books to dissipate his know-how amongst his peers and to the laymen. He has categorically made an effort to bring complex scientific terms into a more understandable frame to help maximum people deduce inferences out of it and add value to their lives and knowledge. Through the course of his illuminated career, Dr. Rakesh Srivastava has edited 5 books in total and written 15 book chapters. Rakesh Srivastava Ph.D., FRSM has several patents to his name and has written 150scientific papers for his peers. Some of the books edited by him are namely “Apoptosis, Cell Signaling, and Human Diseases both volume 1 and volume 2”, Stem Cells and Human Diseases” as well as “Nutrition, Diet and Cancer”. Another book edited by him is called “Lost in Translation”. These books are available on all leading online portals and are up for grabs. He has chaired meetings and delivered keynotes lectures and presentations at many national and international conferences.
Dr. Rakesh Srivastava shoulders the prized position of a senior professor at the Stanley S. Scott Cancer Center, and Department of Genetics, Louisiana State University Health Sciences Centre, New Orleans, LA. He has taught numerous courses like Human Biology, Pharmacology, Principles of Drug Actions, Molecular Cell Biology, Histology, Biochemistry, Physiology, Zoology, Botany, Horticulture, Physiology, Cancer Biology, Toxicology, Endocrinology, Genetics, Cancer Therapeutics, and Anatomy at some of the world’s leading and revered institutions. Prior to his current appointment, Dr. Srivastava worked as an Assistant Professor in the Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD. He was later appointed as the Associate Professor in the Department of Biochemistry, University of Texas Health Science Centre. He was subsequently promoted to the rank of a full professor at the same University. He then worked as a Tyler Endowed Professor in the Dept. of Pharmacology, Toxicology, and Therapeutics, and Medicine, University of Kansas Medical Centre, Kansas City, KS and was also honored as an Eminent Scholar by the Kansas Bioscience Authority at the same time. Dr. Srivastava then worked as a Senior Scientist at the Kansas City VA Medical Centre, Kansas City, MO.
His praiseworthy abilities and talents find mentioned through a lot of books that he has edited and also through all the trailblazing research that he has carried out in the fields of Drug discovery and development, cancer therapy, prevention, diabetes, nutrition, stem cell, autophagy, non-coding RNA, nanotechnology, angiogenesis, metastasis, pharmacology, toxicology, biochemistry. Though all these subjects sound alien to laymen through his extensive research and practice, Dr. Rakesh Srivastava has tried to condense all these complex terminologies into simpler terms so as to make it more appropriate for understanding when it comes to common people and also as a strong reference point for those who have a keen interest in pursuing and undertaking operations pertaining these above-mentioned fields.
What one needs to understand is that the expertise of this degree doesn’t just come from acquired knowledge and skill; it takes something much more than that. Dr. Srivastava has an undying yearning to do something consequential for mankind and he has decided to tread on a path that shall require him to be dedicated to it forever. Subjects like Human Biology, Medicine, Pharmacology, etc. are very crucial topics and cannot be elucidated by someone with such depth and ease unless one posse’s uncanny knowledge, dedication, and abilities like those of Dr. Rakesh Srivastava. He is an encyclopedia of knowledge and we are all fortunate to have such a gifted scientist amongst us.
Dr. Rakesh Srivastava has these high-profile suffixes attached to his name and these speak a lot about his caliber and the advent of his expertise. Dr. Rakesh Srivastava completed his M.Sc. from the Memorial University of Newfoundland, St. John’s, Newfoundland, and PhD. from the University of Guelph, Ontario, Canada. He further pursued Postdoctoral Fellowship at the National Cancer Institute, National Institutes of Health, Bethesda, MD, and subsequently pursued a fellowship at the US National Academy of Sciences. Dr. Rakesh Srivastava has been fortunate enough to imbibe the best education from the world’s leading universities and this celebrated portfolio finds translation in numerous accolades that have been conferred upon him. He has received several Fellowships, Scholarships, and National Merit Awards during his graduate and postgraduate education. He has won the Career Development Award from the Department of Defense, US Army, and Congressionally Directed Medical Research Program. He has been touted as the Eminent Scholar by the Kansas Bioscience Authority and has also been declared a Scholar by the Louisiana Cancer Research Consortium.
Dr. Rakesh Srivastava worked as Scientific Director of GLAX Health. Because of his dedication, talent, extensive knowledge, and entrepreneurship skills, he has been promoted to the President of the company. He holds PMP certification from the Project Management Institute (PMI).
Dr. Srivastava has also provided exemplary services to various national and international committees and has also been appointed as an advisor to several government agencies as well. He holds memberships in the American Association for Cancer Research, American Association for the Advancement of Science, American Association for Cell Biology, Society for Basic Urological Research, Royal Society of Medicine (London), and Royal Society for Public Health (London). All of these are highly revered organizations.
Dr. Rakesh Srivastava is approachable on all leading social media platforms like Facebook, Twitter, LinkedIn, Instagram, etc., and can also be reached at his email which is profsrivastava9@gmail.com. As he is aware of the degree of ambiguity and doubts associated with all the topics in medicine, Dr. Rakesh Srivastava is always keen on interacting with people who wish to know more about human health.
With extensive teaching, leadership, and research experience, Dr. Rakesh Srivastava can provide his services in developing and managing scientific resources, bridging industry, government, and academia, organizing meetings and symposia, and mentoring students and faculty. Dr. Rakesh Srivastava Dr. Rakesh Srivastava
Research interest
DRUG DISCOVERY AND DEVELOPMENT, CANCER THERAPY, PREVENTION, DIABETES, NUTRITION, STEM CELL, AUTOPHAGY, NON-CODING RNA, NANOTECHNOLOGY, ANGIOGENESIS, METASTASIS, PHARMACOLOGY, TOXICOLOGY, BIOCHEMISTRY
Teaching
Human Biology, Pharmacology, Principles of Drug Actions, Molecular Cell Biology, Histology, Biochemistry, Physiology, Zoology, Botany, Horticulture, Physiology, Cancer Biology, Toxicology, Endocrinology, Genetics, Cancer Therapeutics, Anatomy
Services
Already Served in various national and international committees, and also as an advisor to several government agencies.
Contributed in different research and development sectors to help peoples and grow community .
Abstract
Diabetes mellitus (DM), one of the metabolic diseases which is characterized by sustained hyperglycemia, is a life-threatening disease. The global prevalence of DM is on the rise, mainly in low- and middle-income countries. Diabetes is a major cause of blindness, heart attacks, kidney failure, stroke, and lower limb amputation. Type 2 diabetes mellitus (T2DM) is a form of diabetes that is characterized by high blood sugar and insulin resistance. T2DM can be prevented or delayed by a healthy diet, regular physical activity, maintaining normal body weight, and avoiding alcohol and tobacco use. Ethanol and its metabolites can cause differentiation defects in stem cells and promote inflammatory injury and carcinogenesis in several tissues. Recent studies have suggested that diabetes can be treated, and its consequences can be avoided or delayed with proper management. DM has a greater risk for several cancers, such as breast, colorectal, endometrial, pancreatic, gallbladder, renal, and liver cancer. The incidence of cancer is significantly higher in patients with DM than in those without DM. In addition to DM, alcohol abuse is also a risk factor for many cancers. We present a review of the recent studies investigating the association of both DM and alcohol abuse with cancer incidence.
Keywords:alcoholism; bladder cancer; breast cancer; colorectal cancer; diabetes mellitus; gastric cancer; hepatocellular carcinoma; pancreatic cancers.
Conflict of interest statement
The authors declare no conflict of interest.